FEN1 and cancer: The results revealed that this combination not only effectively killed NB cells but also amplified the cytotoxic effects of cisplatin, positioning FEN1 as a promising anti-cancer target and underscoring the potential of its inhibitors to enhance treatment outcomes for NB.